Apogee Therapeutics, Inc. (CIK: 0001974640) EDGAR, Information, Filings... CompaniesBIO.Com

Apogee Therapeutics, Inc.

Mailing address
221 CRESCENT ST., BUILDING 17, SUITE 102B, WALTHAM, Delaware, 02453
Phone
650-394-5230
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Apogee Therapeutics, Inc. (CIK: 0001974640) is an American company incorporated in the state of Massachusetts. Head office is located at 221 CRESCENT ST., BUILDING 17, SUITE 102B, WALTHAM, Massachusetts, 02453. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Apogee Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Apogee Therapeutics, LLC from 2023-28-Apr to 2023-05-Jun

Owner	Filings	Transaction Date	Type of Owner
McKenna Mark C.	0001749623	Aug-17-2023	director
JONES WILLIAM A JR	0001373097	Jul-13-2023	director
Henderson Jane	0001422304	Jul-13-2023	officer: Chief Financial Officer
Harwin Peter Evan	0001663607	Jul-13-2023	director
Fairmount Healthcare Fund L.P.	0001686157	Jul-13-2023	director
Shah Nimish P	0001698082	Jul-13-2023	director
Fairmount Healthcare Fund II L.P.	0001769651	Jul-13-2023	director
HENDERSON MICHAEL THOMAS	0001779990	Jul-13-2023	director, officer: Chief Executive Officer
Fairmount Funds Management LLC	0001802528	Jul-13-2023	director
Kiselak Tomas	0001830177	Jul-13-2023	director
Fox Jennifer A.	0001841557	Jul-13-2023	director
Gottesdiener Andrew	0001972292	Jul-13-2023	director
Fairmount Healthcare Co-Invest II L.P.	0001982189	Jul-13-2023	director
Dambkowski Carl	0001983476	Jul-13-2023	officer: Chief Medical Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Apogee Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-097867 ( Act) Size: 0 KB	Sep-06-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-097866 ( Act) Size: 0 KB	Sep-06-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001000275-24-000074 (33 Act) Size: 0 KB	Sep-04-2024	001-41740 241276707
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-092519 ( Act) Size: 0 KB	Aug-23-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-006425 (33 Act) Size: 0 KB	Aug-23-2024	001-41740 241236407
8-K	Document	Current report filing Acc-no: 0001104659-24-090690 (34 Act) Size: KB	Aug-19-2024	001-41740 241218246
S-3ASR	Document	Automatic shelf registration statement of securities of well-known seasoned issuers Acc-no: 0001104659-24-088446 (33 Act) Size: KB	Aug-12-2024	333-281503 241198038
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001104659-24-088337 (33 Act) Size: KB	Aug-12-2024	333-281477 241196746
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-095053 (34 Act) Size: KB	Aug-12-2024	001-41740 241194690
8-K	Document	Current report filing Acc-no: 0001104659-24-088029 (34 Act) Size: KB	Aug-12-2024	001-41740 241194672
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-087940 ( Act) Size: 0 KB	Aug-09-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-087939 ( Act) Size: 0 KB	Aug-09-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001000275-24-000056 (33 Act) Size: 0 KB	Aug-07-2024	001-41740 241182696
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-078135 ( Act) Size: 0 KB	Jul-05-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-078134 ( Act) Size: 0 KB	Jul-05-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001000275-24-000050 (33 Act) Size: 0 KB	Jul-05-2024	001-41740 241102298
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-005228 (33 Act) Size: 0 KB	Jul-03-2024	001-41740 241099165
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069803 ( Act) Size: 0 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069798 ( Act) Size: 0 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069797 ( Act) Size: 0 KB	Jun-07-2024

Recent 20 filings. View all Apogee Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Apogee Therapeutics, Inc. overview
Apogee Therapeutics, Inc. job
Apogee Therapeutics, Inc. stock
Apogee Therapeutics, Inc. ownership
Apogee Therapeutics, Inc. CEO
Apogee Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.